// App-Quantinova.ai

2926 : Identification of EpHA3 As a New Potential Molecular Target in Multiple Myeloma.

Researchers

Presenter

  • Francesco La Rocca

Principal Investigators

  • Alessandra Favole

  • Stefania Trino

  • Simona Berardi

  • Antonio Basile

  • Angelo Vacca

  • Pellegrino Musto

  • Daniela Cilloni

  • Daniela Cilloni

  • Sonia Carturan

  • Enrico Bracco

  • Oreste Villani

  • Giuseppe Pietrantuono

  • Ilaria Laurenzana

  • Luciana De Luca

  • Annalisa Morano

  • Vittorio Simeon

Medical Centers

  • Department of Onco-Hematology, IRCCS-CROB, Italy,

  • Dept of Clinical and Biological Sciences, University of Turin, Turin, Italy

  • Department of Biomedical Sciences and Human Oncology University of Bari, Bari, Italy

  • University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy

Locations

  • Italy

Companies

  • Translational Resear

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Acute lymphoblastic leukemia

  • Myeloid neoplasms

  • Monoclonal gammopathy

  • Multiple Myeloma

  • T-cell lymphoma

  • Lymphomas

  • Anemia

  • Gastric antral vascular ectasia

Biomarkers

  • Ephrin A5

  • Glycosylphosphatidylinositol

  • TNF Alpha Induced Protein 1

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • Cyanocobalamin

  • L-Tyrosine

  • KB004

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved